X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1874) 1874
Book Review (213) 213
Publication (146) 146
Government Document (23) 23
Conference Proceeding (16) 16
Book Chapter (7) 7
Dissertation (3) 3
Book / eBook (1) 1
Magazine Article (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
prostate cancer (1239) 1239
psma (1039) 1039
index medicus (922) 922
humans (671) 671
male (608) 608
radiology, nuclear medicine & medical imaging (572) 572
cancer (406) 406
pet/ct (356) 356
oncology (355) 355
membrane antigen (308) 308
therapy (277) 277
prostate (275) 275
diagnosis (271) 271
pet (265) 265
expression (252) 252
prostate-specific membrane antigen (244) 244
prostatic neoplasms - pathology (228) 228
antigens (227) 227
animals (205) 205
medicine & public health (203) 203
prostatic neoplasms - diagnostic imaging (197) 197
aged (188) 188
radical prostatectomy (188) 188
urology & nephrology (179) 179
ga-68-labeled psma ligand (178) 178
biochemical recurrence (176) 176
metastasis (171) 171
membrane antigen psma (170) 170
tomography (165) 165
glutamate carboxypeptidase ii - metabolism (163) 163
cell line, tumor (162) 162
imaging / radiology (162) 162
nuclear medicine (162) 162
middle aged (152) 152
mice (151) 151
antigens, surface - metabolism (142) 142
tumors (141) 141
urologic and male genital diseases (136) 136
metastases (135) 135
carcinoma (132) 132
positron-emission-tomography (131) 131
prostatic neoplasms - metabolism (131) 131
prostate-cancer (130) 130
article (127) 127
ligands (125) 125
radioligand therapy (123) 123
positron emission tomography (117) 117
cardiology (113) 113
orthopedics (113) 113
psa (113) 113
radiation-dosimetry (110) 110
pet imaging (108) 108
positron emission (108) 108
care and treatment (107) 107
computed tomography (106) 106
prostate-specific antigen (106) 106
prostatic neoplasms - therapy (106) 106
positron emission tomography computed tomography (105) 105
patients (104) 104
radiopharmaceuticals (102) 102
membrane antigen-expression (100) 100
cells (99) 99
ligand (98) 98
radiotherapy (96) 96
medical imaging (94) 94
biochemistry & molecular biology (91) 91
ga-68-psma pet/ct (90) 90
prostatic neoplasms - diagnosis (90) 90
positron-emission tomography (86) 86
research (86) 86
recurrence (85) 85
health aspects (82) 82
prostata (80) 80
radionuclide therapy (80) 80
tumor (80) 80
aged, 80 and over (79) 79
antigen (79) 79
dosimetry (78) 78
usage (78) 78
molecular imaging (77) 77
inhibitors (75) 75
preclinical evaluation (75) 75
adenocarcinoma (74) 74
hbed-cc (73) 73
mri (73) 73
magnetic resonance imaging (72) 72
prostatic neoplasms - drug therapy (72) 72
biodistribution (71) 71
endocrinology & metabolism (71) 71
immunotherapy (71) 71
prostatic neoplasms - immunology (70) 70
medicine, research & experimental (69) 69
edetic acid - analogs & derivatives (68) 68
pharmacology & pharmacy (66) 66
glutamate carboxypeptidase ii (65) 65
analysis (64) 64
chemistry, medicinal (64) 64
prostate specific membrane antigen (64) 64
prostate-specific antigen - metabolism (64) 64
antibodies (63) 63
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1834) 1834
German (31) 31
French (27) 27
Spanish (16) 16
Dutch (3) 3
Korean (2) 2
Chinese (1) 1
Czech (1) 1
Italian (1) 1
Japanese (1) 1
Portuguese (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 1/2016, Volume 43, Issue 1, pp. 34 - 41
Radiotherapy is the main therapeutic approach besides surgery of localized prostate cancer. It relies on risk stratification and exact staging. This report... 
Radiotherapy planning | Medicine & Public Health | 68 Ga-PSMA ligand PET/CT | Orthopedics | Individualized radiotherapy | Oncology | Nuclear Medicine | Imaging / Radiology | Cardiology | Prostate cancer | Ga-PSMA ligand PET/CT | 68Ga-PSMA ligand PET | Original
Journal Article
European Urology, ISSN 0302-2838, 11/2016, Volume 70, Issue 5, pp. 829 - 836
Ligands of the prostate-specific membrane antigen (PSMA) show promising results in positron emission tomography (PET) imaging of prostate cancer (PCa). To... 
Primary prostate cancer | Histopathology | Localization | mpMRI | 68Ga-PSMA HBED-CC PET/MRI | Ga-PSMA HBED-CC PET/MRI | Index Medicus
Journal Article
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, ISSN 1619-7070, 07/2014, Volume 41, Issue 7, pp. 1280 - 1292
Introduction Since the prostate-specific membrane antigen (PSMA) is frequently over-expressed in prostate cancer (PCa) several PSMA-targeting molecules are... 
J591 | TISSUE | SENSITIVITY | Biodistribution | MEMBRANE ANTIGEN PSMA | Absorbed dose estimates | PSMA targeting | PHASE-I TRIAL | Dosimetry | INHIBITORS | Prostatecancer | Radioiodinated PSMA ligand | MONOCLONAL-ANTIBODIES | EXPRESSION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 03/2016, Volume 43, Issue 3, pp. 397 - 403
Journal Article
Oncotarget, ISSN 1949-2553, 09/2018, Volume 9, Issue 70, pp. 33312 - 33321
Prostate cancer is most common tumor in men causing significant patient mortality and morbidity. In newer diagnostic/therapeutic agents PSMA linked ones are... 
Tumor textural heterogeneity | Lu-PSMA therapy | Ga-PSMA | Prostate cancer | Response prediction
Journal Article
Clinical Nuclear Medicine, ISSN 0363-9762, 01/2018, Volume 43, Issue 1, pp. 38 - 40
ABSTRACTTwo, respectively, 72- and 76-year-old men with recently diagnosed high-risk prostate cancer were referred for primary staging with... 
68Ga-PSMA | Fracture | Rib fracture | Prostate cancer | PSMA PET/CT | Pitfall | BONE-DISEASE | METASTASIS | PAGET DISEASE | HEMANGIOMA | GA-68-PSMA LIGAND PET/CT | Ga-68-PSMA | fracture | pitfall | prostate cancer | 68GA-PSMA PET/CT | rib fracture | PSMA PET | PSMA-PET | EXPRESSION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | MYELOMA | Index Medicus
Journal Article
European Urology, ISSN 0302-2838, 08/2018, Volume 74, Issue 2, pp. 179 - 190
Gallium prostate-specific membrane antigen positron emission tomography ( Ga-PSMA PET) is an emerging imaging modality for assessment of prostate cancer.... 
Impact | Systematic review | 68Ga-PSMA PET | Prostate cancer | Meta-analysis | Ga-PSMA PET | Index Medicus
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 1/2016, Volume 43, Issue 1, pp. 70 - 83
To evaluate the reproducibility of the combination of hybrid PET/MRI and the 68Ga-PSMA-11 tracer in depicting lymph node (LN) and bone metastases of prostate... 
68 Ga-PSMA | PSMA | PET/MRI | Medicine & Public Health | Lymph node metastases | Orthopedics | PET/CT | Oncology | Nuclear Medicine | Imaging / Radiology | Cardiology | Bone metastases | Ga-PSMA
Journal Article
JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 07/2016, Volume 57, Issue 7, pp. 1006 - 1013
The objective of this study was to analyze the safety and efficacy of the Lu-177-labeled DOTAGA-based prostate-specific membrane antigen (PSMA) ligand... 
RADIATION-DOSIMETRY | SURVIVAL | PSMA INHIBITOR | PSMA | GA-68 | RECOMMENDATIONS | radioligand therapy | PET/CT | theranostics | RECEPTOR RADIONUCLIDE THERAPY | TISSUES | PROBE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 05/2015, Volume 56, Issue 5, pp. 668 - 674
The expression of prostate-specific membrane antigen (PSMA) is increased in prostate cancer. Recently, Ga-68-PSMA (Glu-NH-CO-NH-Lys-(Ahx)-[Ga-68(HBED-CC)]) was... 
CANCER PATIENTS | GA-68-LABELED PSMA LIGAND | PSMA ligand | hybrid imaging | MEMBRANE ANTIGEN-EXPRESSION | biochemical recurrence | LYMPH-NODE METASTASES | RELAPSE | prostate cancer | C-11-CHOLINE PET/CT | POSITRON-EMISSION-TOMOGRAPHY | PSA KINETICS | PET/CT | DISEASE | EXPERIENCE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 02/2017, Volume 58, Issue 2, pp. 235 - 242
Initial studies in patients have demonstrated the suitability of In-111-PSMA-I&T (In-111-DOTAGA-(3-iodo-y)-f-k-Sub(KuE)) (PSMA is prostate specific membrane... 
RADIATION-DOSIMETRY | DIAGNOSIS | MEMBRANE ANTIGEN | gamma probe | F-18-DCFBC PET/CT | SPECT | PSMA INHIBITOR | In-111-PSMA-I&T | PSMA | THERAPY | PHARMACOKINETICS | radioguided surgery | SMALL-MOLECULE INHIBITORS | Tc-99m-PSMA-I&S | LIGAND | ENDORADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RGS
Journal Article